Back to Search Start Over

Rethinking the appraisal and approval of drugs for type 2 diabetes

Authors :
John S Yudkin
Olivier J. Wouters
Richard Lehman
Huseyin Naci
Ben Goldacre
Source :
BMJ. :h5260
Publication Year :
2015
Publisher :
BMJ, 2015.

Abstract

The process for approving new drugs for type 2 diabetes illustrates the significant shortcomings of the regulatory standards for licensing, reimbursing, and adopting new drugs. Regulatory reform is needed to improve the real-world therapeutic value of anti-diabetic drugs.

Subjects

Subjects :
medicine.medical_specialty
United States Food and Drug Administration
business.industry
Alternative medicine
General Medicine
Type 2 diabetes
Pharmacology
medicine.disease
United States
Diabetes Mellitus, Type 2
Family medicine
RA Public aspects of medicine
Drug approval
Humans
Hypoglycemic Agents
Medicine
business
Drug Approval

Details

ISSN :
17561833
Database :
OpenAIRE
Journal :
BMJ
Accession number :
edsair.doi.dedup.....ef0784c85b9b646d3558fe75dd8082fd

Tools

Authors Abstract Subjects Details